Molecular Mechanisms of Sensorineural Hearing Loss and Development of Inner Ear Therapeutics

The sense of hearing is vulnerable to environmental challenges, such as exposure to noise. More than 1.5 billion people experience some decline in hearing ability during their lifetime, of whom at least 430 million will be affected by disabling hearing loss. If not identified and addressed in a time...

Full description

Saved in:
Bibliographic Details
Sonstige:
Year of Publication:2021
Language:English
Physical Description:1 electronic resource (5793 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 04082nam-a2200865z--4500
001 993545265704498
005 20231214132847.0
006 m o d
007 cr|mn|---annan
008 202201s2021 xx |||||o ||| 0|eng d
035 |a (CKB)5400000000043169 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/76840 
035 |a (EXLCZ)995400000000043169 
041 0 |a eng 
100 1 |a Vlajkovic, Srdjan M  |4 edt 
245 1 0 |a Molecular Mechanisms of Sensorineural Hearing Loss and Development of Inner Ear Therapeutics 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2021 
300 |a 1 electronic resource (5793 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a The sense of hearing is vulnerable to environmental challenges, such as exposure to noise. More than 1.5 billion people experience some decline in hearing ability during their lifetime, of whom at least 430 million will be affected by disabling hearing loss. If not identified and addressed in a timely way, hearing loss can severely reduce the quality of life at various stages. Some causes of hearing loss can be prevented, for example from occupational or leisure noise. The World Health Organization estimates that more than 1 billion young people put themselves at risk of permanent hearing loss by listening to loud music over long periods of time. Mitigating such risks through public health action is essential to reduce the impact of hearing loss in the community. The etiology of sensorineural hearing loss is complex and multifactorial, arising from congenital and acquired causes. This book highlights the diverse range of approaches to sensorineural hearing loss, from designing new animal models of age-related hearing loss, to the use of microRNAs as biomarkers of cochlear injury and drug repurposing for the therapy of age-related and noise-induced hearing loss. Further investigation into the underlying molecular mechanisms of sensorineural hearing loss and the integration of the novel drug, cell, and gene therapy strategies into controlled clinical studies will permit significant advances in a field where there are currently many unmet needs. 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a brain-derived neurotrophic factor 
653 |a TrkB 
653 |a inner ear 
653 |a development 
653 |a zebrafish 
653 |a mitochondria dysfunction 
653 |a reactive oxygen species 
653 |a hypoxic 
653 |a d-galactose 
653 |a high-fat diet 
653 |a aging 
653 |a hearing loss 
653 |a astrocytes 
653 |a auditory brainstem 
653 |a lateral superior olive 
653 |a gap junctions 
653 |a voltage-activated calcium channel 1.3 
653 |a otoferlin 
653 |a spontaneous activity 
653 |a deafness 
653 |a circadian dysregulation 
653 |a clock genes 
653 |a noise-induced hearing loss 
653 |a sensory hair cells 
653 |a synaptic ribbons 
653 |a sensorineural hearing loss 
653 |a hyperbaric oxygenation 
653 |a adjunctive therapy 
653 |a microRNAs 
653 |a cochlear nucleus 
653 |a inferior colliculus 
653 |a neuroplasticity 
653 |a noise-induced cochlear injury 
653 |a cochlear rescue 
653 |a otoprotection 
653 |a adenosine A1 receptor 
653 |a regulator of G protein signalling 4 
653 |a CCG-4986 
653 |a intratympanic drug delivery 
653 |a potassium voltage-gated channel subfamily q member 4 
653 |a potassium 
653 |a nonsyndromic hearing loss 
653 |a KCNQ4 activator 
653 |a age-related hearing loss 
653 |a selegiline 
653 |a chronic oral treatment 
653 |a hearing protection 
653 |a mouse model 
776 |z 3-0365-1506-2 
776 |z 3-0365-1505-4 
700 1 |a Vlajkovic, Srdjan M  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 05:34:25 Europe/Vienna  |f system  |c marc21  |a 2022-04-04 09:22:53 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337862270004498&Force_direct=true  |Z 5337862270004498  |b Available  |8 5337862270004498